Canakinumab
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Product Specifications
CAS Number
914613-48-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Bis[4- (Diphenylsulfonio) phenyl] Sulfide Bis (hexafluoroantimonate)](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS4381551-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
BCL10 (MALT-Lymphoma Marker)
Ask
View Details MBS4381551-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)
BCL10 (MALT-Lymphoma Marker)
Ask
View Details